Orally administered DTPA di-ethyl ester for decorporation of ²⁴¹Am in dogs: Assessment of safety and efficacy in an inhalation-contamination model

References

• Allison G. 2010. A failure to imagine the worst. Foreign Policy. Slate Group. Available from: http://foreignpolicy.com/2010/01/22/a-failure-to-imagine-the-worst [cited 12 June 2014].
   Google Scholar
• Ames BN, Mccann J, Yamasaki E. 1975. Methods for detecting carcinogens and mutagens with Salmonella-mammalian-microsome mutagenicity test. Mutat Res 31:347–363.
   PubMed Web of Science ®Google Scholar
• Bailey MR, Kreyling WG, Andre S, Batchelor A, Collier CG, Drosselmeyer E, Ferron GA, Foster P, Haider B, Hodgson A, Masse R, Metivier H, Morgan A, Muller HL, Patrick G, Pearman I, Pickering S, Ramsden D, Stirling C, Talbot RJ. 1989. An interspecies comparison of the lung clearance of inhaled monodisperse cobalt oxide particles. 1. Objectives and summary of results. J Aerosol Sci 20:169–188.
   Web of Science ®Google Scholar
• Beaumont K, Webster R, Gardner I, Dack K. 2003. Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: Challenges to the discovery scientist. Curr Drug Metab 4:461–485.
   PubMed Web of Science ®Google Scholar
• Bruenger FW, Kuswikrabiega G, Miller SC. 1992. Decorporation of aged americium deposits by oral-administration of lipophilic polyamino carboxylic-acids. J Med Chem 35:112–118.
   PubMed Web of Science ®Google Scholar
• Cassatt DR, Kaminski JM, Hatchett RJ, DiCarlo AL, Benfamin JM, Maidment BW. 2008. Medical countermeasures against nuclear threats: Radionuclide decorporation agents. Rad Res 170:540–548.
   PubMed Web of Science ®Google Scholar
• Doyle-Eisele M, Weber W, Melo DR, Guilmette RA. 2014. Whole-body distribution of americium in rats for different pathways of intake. Int J Radiat Biol 90:1068–74.
   PubMed Web of Science ®Google Scholar
• Durbin PW. 2006. Actinides in animals and man. In: Morss LR. Edelstein NM, Fuger J, editors. The chemistry of the actinide and transactinide elements. The Netherlands: Springer. pp 3339–3440.
   Google Scholar
• Food and Drug Administration (FDA). 2014. Guidence for industry: Product development under the Animal Rule (draft guidance) Silver Spring, MD. Available at: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm399217.pdf [cited 12 June 2014].
   Google Scholar
• Food and Drug Administration (FDA). 2012. International conference on harmonisation; guidance on S2(R1) genotoxicity testing and data interpretation for pharmaceuticals intended for human use. Fedral Registar 77:33748–33749.
   PubMedGoogle Scholar
• Fukuda S, Iida H. 1987. Toxicological study of DTPA as a drug (III), side effects of orally administered Zn-DTPA to beagle dogs. Jap J Health Phys 22:439–444.
   Google Scholar
• Fukuda S, Iida H, Yamagiwa J. 1984. Toxicological study of DTPA as a drug (II), chronic side effects of orally administered DTPA to rats. Jap J Health Phys 19:119–126.
   Google Scholar
• Green MHL, Muriel WJ. 1976. Mutagen testing using Trp+ reversion in Escherichia coli. Mutat Res 38:3–32.
   PubMed Web of Science ®Google Scholar
• Guilmette RA, Parks JE, Lindenbaum A. 1979. Synthesis and therapeutic testing of mono- and dialkyl esters of pentetic (Diethylenetriaminepentaacetic) acid for decorporation of polymeric plutonium. J Pharm Sci 68:194–196.
   PubMed Web of Science ®Google Scholar
• International Commission on Radiological Protection (ICRP). 1979. International Commission on Radiological Protection. Limits for intakes of radionuclides by workers. ICRP 30, Part 1. Ann ICRP 2 (3–4). Oxford/New York: Pergamon Press.
   Google Scholar
• Lloyd RD, Jones CW, Taylor GN, Mays <, Atherton DR. 1979. Pu and Am decorporation in beagles: Effects of magnitude of initial Ca-DTPA injection upon chelation efficacy. Radiat Res 79:630–634.
   PubMed Web of Science ®Google Scholar
• Markley JF. 1963. Removal of polymeric plutonium from mice by combined therapy with the calcium chelate and penta-ethyl ester of DTPA. Int J Radiat Biol Relat Stud Phys Chem Med 7:405–407.
   PubMed Web of Science ®Google Scholar
• Miller SC, Wang XL, Bowman BM. 2010. Pharmacological properties of orally available, amphipathic polyaminocarboxylic acid chelators for actinide decorporation. Health Phys 99:408–412.
   PubMed Web of Science ®Google Scholar
• Reddy JD, Cobb RR, Dungan NW, Matthews LL, Aiello KV, Ritter G, Eppler B, Kirk JF, Abernethy JA, Tomisaka DM, Talton JD. 2012. Preclinical toxicology, pharmacology, and efficacy of a novel orally administered Diethylenetriaminepentaacetic acid (DTPA) formulation. Drug Dev Res 73:232–242.
   Web of Science ®Google Scholar
• Seidel A. 1975. Removal from rat of internally deposited Am-241 by long-term treatment with Cadtpa and Zndtpa. Radiat Res 61: 478–487.
   PubMed Web of Science ®Google Scholar
• Shankar GN, Potharaju S, Green CE. 2014. Evaluating the toxicity of novel Zn-DTPA tablet formulation in dogs and rats. Drug Dev Res 75:37–46.
   PubMed Web of Science ®Google Scholar
• Snipes MB. 1989. Long-Term retention and clearance of particles inhaled by mammalian-species. Crit Rev Toxicol 20:175–211.
   PubMed Web of Science ®Google Scholar
• Stella VJ, Nti-Addae KW. 2007. Prodrug strategies to overcome poor water solubility. Adv Drug Delivery Rev 59:677–694.
   PubMed Web of Science ®Google Scholar
• Sueda K, Sadgrove MP, Fitzsimmons JM, Jay M. 2012. Physicochemical characterization of a prodrug of a radionuclide decorporation agent for oral delivery. J Pharm Sci 101:2844–2853.
   PubMed Web of Science ®Google Scholar
• Sueda K, Sadgrove MP, Huckle JE, Leed MGD, Weber WM, Doyle-Eisele M, Guilmette RA, Jay M. 2014. Orally administered DTPA penta-ethyl ester for the decorporation of inhaled 241Am. J Pharm Sci 103:1563–1571.
   PubMed Web of Science ®Google Scholar
• Volf V. 1984. Effect of drinking Zn-Dtpa on Pu-238 and Am-241 in rat bones. Radiat Environ Biophys 23:141–143.
   PubMed Web of Science ®Google Scholar
• Yaes RJ. 2004. DTPA Medical Officer review. Center for Drug Evalulation and Research, FDA, Silver Spring, MD. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21–749_Pentetate%20Calcium%20and%20Zinc_medr_P1.pdf [cited 12 June 2014].
   Google Scholar
• Zhang Y, Sadgrove MP, Mumper RJ, Jay M. 2013a. Radionuclide decorporation: matching the biokinetics of actinides by transdermal delivery of Pro-chelators. AAPS J 15:1180–1188.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sadgrove MP, Sueda K, Yang YT, Pacyniak EK, Kagel JR, Braun BA, Zamboni WC, Mumper RJ, Jay M. 2013b. Nonaqueous gel for the transdermal delivery of a DTPA penta-ethyl ester prodrug. AAPS J 15:523–532.
   PubMed Web of Science ®Google Scholar